Veterinary Orthopedic Implants Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

The Global Veterinary Orthopedic Implants Market was valued at USD 622.9 million in 2024 and is estimated to grow at a CAGR of 8.3% to reach USD 1.4 billion by 2034, driven by the growing incidence of orthopedic conditions in companion animals, advancements in veterinary orthopedic technology, and the expanding coverage of pet insurance. Veterinary orthopedic implants are increasingly used to treat fractures, joint disorders, and musculoskeletal injuries in small, medium, and large animals, offering improved quality of life and mobility. Innovations in implant materials, such as titanium and bioresorbable polymers, combined with minimally invasive surgical techniques, are enhancing treatment outcomes and reducing recovery times for animals.

The rising trend of pet humanization and the growing willingness among pet owners to invest in advanced veterinary treatments are key factors fueling market growth. The increasing prevalence of conditions like cranial cruciate ligament injuries, osteoarthritis, and hip dysplasia, particularly among large and aging dog breeds, has created a strong demand for orthopedic surgical interventions. Furthermore, the emergence of 3D-printed customized implants, patient-specific surgical solutions, and smart implants equipped with sensors is redefining standards of care in veterinary orthopedics, encouraging broader adoption across veterinary clinics and specialty hospitals.

The veterinary orthopedic implants market is primarily segmented by product, with implants leading in 2024, generating USD 442 million. Veterinary implants, including plates, bone screws, joint implants, and pins, are extensively used to restore mobility and correct fractures in animals. Among these, plates such as Tibial Plateau Leveling Osteotomy (TPLO) and Tibial Tuberosity Advancement (TTA) plates are widely adopted for treating cranial cruciate ligament injuries in dogs. The increasing preference for lightweight, durable, and biocompatible implants, along with the introduction of locking plate technology and bioresorbable implants, is further driving segment expansion.

In terms of animal type, small and medium animals accounted for the largest market share and is estimated to expand at a CAGR of 8.5% from 2025 to 2034, fueled by the rising pet ownership rates and growing veterinary care expenditures globally. Dogs and cats dominate the demand for orthopedic implants, particularly for conditions like hip dysplasia, joint replacements, and traumatic injuries. The strong emotional bond between pet owners and their animals has resulted in higher investments in veterinary treatments, with pet owners increasingly opting for surgical interventions to enhance their pets' quality of life and longevity.

North America Veterinary Orthopedic Implants Market reached USD 261.1 million in 2024, driven by the region's advanced veterinary healthcare infrastructure, high pet ownership rates, and increased awareness about orthopedic health in animals. The U.S. leads the market with significant expenditures on pet healthcare and a well-established insurance ecosystem that makes expensive orthopedic surgeries more accessible. Rising demand for innovative orthopedic solutions, including custom implants and minimally invasive procedures, coupled with supportive regulatory environments, is further strengthening North America's dominance in the global market.

Companies such as AmerisourceBergen Corporation (Cencora, Inc.), Arthrex Vet Systems, B. Braun, DePuy Synthes (Johnson & Johnson), Fusion Implants, Integra LifeSciences, Movora (Vimian Group), and Veterinary Instrumentation are enhancing their market positions through new product innovations, strategic acquisitions, and collaborations. These players are focusing on developing advanced implant technologies, including 3D-printed and bioresorbable options, to meet the evolving demands of veterinary practitioners. Investments in expanding their global footprint, improving surgical training programs, and strengthening supply chains are crucial strategies enabling these companies to maintain a competitive edge in the growing veterinary orthopedic implants market.


Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Data mining approach
1.4.2 Approach 2: Bottom-up approach
1.4.3 Approach 3: Parent market analysis
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources 23
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Animal type trends
2.1.5 Application trends
2.1.6 End use trends
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing incidence of orthopedic conditions in dogs
3.2.1.2 Advancement in veterinary orthopedic technology
3.2.1.3 Expansion of pet insurance coverage
3.2.2 Industry pitfalls
3.2.2.1 High cost of orthopedic procedures and implants
3.3 Growth potential analysis
3.3.2 By animal type
3.3.3 By application
3.3.4 By end use
3.4 Regulatory landscape
3.4.1 U.S. (FDA & USDA)
3.4.2 Europe (EMA & MDR)
3.4.3 Asia Pacific
3.4.4 Latin America
3.5 Technology landscape
3.6 Future market trend
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.1.1 AmerisourceBergen Corporation (Cencora, Inc.)
4.1.2 DePuy Synthes (Johnson & Johnson)
4.1.3 Movora (Vimian Group AB)
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Veterinary Orthopedic Implants Market, By Product
5.1 Implants
5.1.1 Plates
5.1.1.1 TPLO plates 60
5.1.1.2 TTA plates 60
5.1.1.3 Specialty plates
5.1.1.4 Trauma plates
5.1.1.5 Other plates 61
5.1.2 Joint implants
5.1.3 Bone screw and anchors
5.1.4 Pins and wires
5.1.5 Other implants
5.2 Instruments
Chapter 6 Veterinary Orthopedic Implants Market, By Animal Type
6.1 Small and medium animals
6.1.1 Dogs
6.1.2 Cats
6.1.3 Other small and medium animals
6.2 Large animals
Chapter 7 Veterinary Orthopedic Implants Market, By Application
7.1 Tibial plateau leveling osteotomy (TPLO)
7.2 Tibial tuberosity advancement (TTA)
7.3 Joint replacement
7.3.1 Hip replacement
7.3.2 Knee replacement
7.3.3 Elbow replacement
7.3.4 Ankle replacement
7.4 Trauma
7.5 Other applications
Chapter 8 Veterinary Orthopedic Implants Market, By End Use
8.1 Veterinary hospitals and clinics
8.2 Other end users
Chapter 9 Veterinary Orthopedic Implants Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profiles
10.1 AmerisourceBergen Corporation (Cencora, Inc.)
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.3.1 Annual sales revenue, 2021-2024 (USD Million)
10.1.4 Product landscape
10.1.5 SWOT analysis
10.2 Arthrex Vet Systems
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.4 Product landscape
10.2.5 Strategic outlook
10.2.6 SWOT analysis
10.3 B. Braun
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.3.4 Product landscape
10.3.5 SWOT analysis
10.4 BlueSAO
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.4 Product landscape
10.4.5 SWOT analysis
10.5 DePuy Synthes (Johnson & Johnson)
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.5.4 Product landscape
10.5.5 Strategic outlook
10.5.6 SWOT analysis
10.6 Fusion Implants
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.4 Product landscape
10.6.5 SWOT analysis
10.7 GerVetUSA
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.4 Product landscape
10.7.5 SWOT analysis
10.8 GPC Medical Ltd.
10.8.1 Global overview
10.8.2 Business overview
10.8.3 Financial data
10.8.4 Product landscape
10.8.5 SWOT analysis
10.9 Integra LifeSciences
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.9.4 Product landscape
10.9.5 SWOT analysis
10.10 Movora (Vimian Group)
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.10.4 Product landscape
10.10.5 Strategic outlook
10.10.6 SWOT analysis
10.11 Narang Medical Limited
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.4 Product landscape
10.11.5 SWOT analysis
10.12 Ortho Max Mfg. Co. Pvt. Ltd.
10.12.1 Global overview
10.12.2 Business overview
10.12.3 Financial data
10.12.4 Product landscape
10.12.5 SWOT analysis
10.13 Orthomed (UK) Ltd
10.13.1 Global overview
10.13.2 Business overview
10.13.3 Financial data
10.13.4 Product landscape
10.13.5 SWOT analysis
10.14 Rita Leibinger GmbH & Co. KG
10.14.1 Global overview
10.14.2 Business overview
10.14.3 Financial data
10.14.4 Product landscape
10.14.5 SWOT analysis
10.15 Veterinary Instrumentation
10.15.1 Global overview
10.15.2 Business overview
10.15.3 Financial data
10.15.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.15.4 Product landscape
10.15.5 Strategic outlook
10.15.6 SWOT analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings